516 related articles for article (PubMed ID: 25783748)
1. BMP-2-transduced human bone marrow stem cells enhance neo-bone formation in a rat critical-sized femur defect.
Müller CW; Hildebrandt K; Gerich T; Krettek C; van Griensven M; Rosado Balmayor E
J Tissue Eng Regen Med; 2017 Apr; 11(4):1122-1131. PubMed ID: 25783748
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect.
Bougioukli S; Jain A; Sugiyama O; Tinsley BA; Tang AH; Tan MH; Adams DJ; Kostenuik PJ; Lieberman JR
Bone; 2016 Mar; 84():93-103. PubMed ID: 26723577
[TBL] [Abstract][Full Text] [Related]
3. Synergetic effects of hBMSCs and hPCs in osteogenic differentiation and their capacity in the repair of critical-sized femoral condyle defects.
Chen D; Shen H; He Y; Chen Y; Wang Q; Lu J; Jiang Y
Mol Med Rep; 2015 Feb; 11(2):1111-9. PubMed ID: 25373389
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study.
Chen SH; Wang XL; Xie XH; Zheng LZ; Yao D; Wang DP; Leng Y; Zhang G; Qin L
Acta Biomater; 2012 Aug; 8(8):3128-37. PubMed ID: 22543006
[TBL] [Abstract][Full Text] [Related]
5. Adipose-derived stem cells and BMP2: part 1. BMP2-treated adipose-derived stem cells do not improve repair of segmental femoral defects.
Chou YF; Zuk PA; Chang TL; Benhaim P; Wu BM
Connect Tissue Res; 2011 Apr; 52(2):109-18. PubMed ID: 20701464
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of In Vivo Osteogenic Potential of Bone Morphogenetic Protein 2-Overexpressing Human Periodontal Ligament Stem Cells Combined with Biphasic Calcium Phosphate Block Scaffolds in a Critical-Size Bone Defect Model.
Yi T; Jun CM; Kim SJ; Yun JH
Tissue Eng Part A; 2016 Mar; 22(5-6):501-12. PubMed ID: 26825430
[TBL] [Abstract][Full Text] [Related]
7. Factors of osteogenesis influencing various human stem cells on third-generation gelatin/β-tricalcium phosphate scaffold material.
Weinand C; Nabili A; Khumar M; Dunn JR; Ramella-Roman J; Jeng JC; Jordan MH; Tabata Y
Rejuvenation Res; 2011 Apr; 14(2):185-94. PubMed ID: 21235414
[TBL] [Abstract][Full Text] [Related]
8. BMP-silk composite matrices heal critically sized femoral defects.
Kirker-Head C; Karageorgiou V; Hofmann S; Fajardo R; Betz O; Merkle HP; Hilbe M; von Rechenberg B; McCool J; Abrahamsen L; Nazarian A; Cory E; Curtis M; Kaplan D; Meinel L
Bone; 2007 Aug; 41(2):247-55. PubMed ID: 17553763
[TBL] [Abstract][Full Text] [Related]
9. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
[TBL] [Abstract][Full Text] [Related]
10. The effect of bone morphogenic protein-2-coated tri-calcium phosphate/hydroxyapatite on new bone formation in a rat model of femoral distraction osteogenesis.
Yang JH; Kim HJ; Kim SE; Yun YP; Bae JH; Kim SJ; Choi KH; Song HR
Cytotherapy; 2012 Mar; 14(3):315-26. PubMed ID: 22122301
[TBL] [Abstract][Full Text] [Related]
11. The role of transduced bone marrow cells overexpressing BMP-2 in healing critical-sized defects in a mouse femur.
Pensak M; Hong S; Dukas A; Tinsley B; Drissi H; Tang A; Cote M; Sugiyama O; Lichtler A; Rowe D; Lieberman JR
Gene Ther; 2015 Jun; 22(6):467-75. PubMed ID: 25809463
[TBL] [Abstract][Full Text] [Related]
12. Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release.
Brown KV; Li B; Guda T; Perrien DS; Guelcher SA; Wenke JC
Tissue Eng Part A; 2011 Jul; 17(13-14):1735-46. PubMed ID: 21338268
[TBL] [Abstract][Full Text] [Related]
13. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue.
Peterson B; Zhang J; Iglesias R; Kabo M; Hedrick M; Benhaim P; Lieberman JR
Tissue Eng; 2005; 11(1-2):120-9. PubMed ID: 15738667
[TBL] [Abstract][Full Text] [Related]
14. Chondroitin Sulfate Glycosaminoglycan Scaffolds for Cell and Recombinant Protein-Based Bone Regeneration.
Andrews S; Cheng A; Stevens H; Logun MT; Webb R; Jordan E; Xia B; Karumbaiah L; Guldberg RE; Stice S
Stem Cells Transl Med; 2019 Jun; 8(6):575-585. PubMed ID: 30666821
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived mesenchymal stem cells assembled with low-dose BMP-2 in a three-dimensional hybrid construct enhances posterolateral spinal fusion in syngeneic rats.
Hu T; Abbah SA; Toh SY; Wang M; Lam RW; Naidu M; Bhakta G; Cool SM; Bhakoo K; Li J; Goh JC; Wong HK
Spine J; 2015 Dec; 15(12):2552-63. PubMed ID: 26342750
[TBL] [Abstract][Full Text] [Related]
16. rhBMP2-loaded calcium phosphate cements combined with allogenic bone marrow mesenchymal stem cells for bone formation.
Luo G; Huang Y; Gu F
Biomed Pharmacother; 2017 Aug; 92():536-543. PubMed ID: 28577492
[TBL] [Abstract][Full Text] [Related]
17. An analysis of bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein 2 from a biodegradable sponge composed of gelatin and β-tricalcium phosphate.
Fujita N; Matsushita T; Ishida K; Sasaki K; Kubo S; Matsumoto T; Kurosaka M; Tabata Y; Kuroda R
J Tissue Eng Regen Med; 2012 Apr; 6(4):291-8. PubMed ID: 21706776
[TBL] [Abstract][Full Text] [Related]
18. Gene Therapy for Bone Repair Using Human Cells: Superior Osteogenic Potential of Bone Morphogenetic Protein 2-Transduced Mesenchymal Stem Cells Derived from Adipose Tissue Compared to Bone Marrow.
Bougioukli S; Sugiyama O; Pannell W; Ortega B; Tan MH; Tang AH; Yoho R; Oakes DA; Lieberman JR
Hum Gene Ther; 2018 Apr; 29(4):507-519. PubMed ID: 29212377
[TBL] [Abstract][Full Text] [Related]
19. RGD and BMP-2 mimetic peptide crosstalk enhances osteogenic commitment of human bone marrow stem cells.
Bilem I; Chevallier P; Plawinski L; Sone ED; Durrieu MC; Laroche G
Acta Biomater; 2016 May; 36():132-42. PubMed ID: 27000551
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo gene therapy using human bone marrow cells overexpressing BMP-2: "Next-day" gene therapy versus standard "two-step" approach.
Bougioukli S; Alluri R; Pannell W; Sugiyama O; Vega A; Tang A; Skorka T; Park SH; Oakes D; Lieberman JR
Bone; 2019 Nov; 128():115032. PubMed ID: 31398502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
